Welcome to our dedicated page for Genix Pharmaceut news (Ticker: GENPF), a resource for investors and traders seeking the latest updates and insights on Genix Pharmaceut stock.
Genix Pharmaceuticals Corporation (GENPF) drives innovation in ophthalmic therapeutics and evidence-based nutraceuticals. This dedicated news hub provides stakeholders with timely updates on regulatory milestones, financial disclosures, and research breakthroughs.
Access authoritative reports on GENPF's global operations, including developments in proprietary OTC formulations and generic drug pipelines. Our curated feed features essential updates ranging from executive leadership decisions to international market expansions.
Key coverage areas: Quarterly financial results • FDA submissions and approvals • Strategic partnerships • Product pipeline advancements • Intellectual property developments. Bookmark this page for direct access to primary source materials and unfiltered corporate communications.
Genix Pharmaceuticals (GENPF) corrected terms for a recently closed non‑brokered private placement announced earlier. The Company clarified the Unit issue price was $0.05 per Unit (not $0.10). The Company issued 2,000,000 Units at $0.05 for total gross proceeds of $100,000. Each Unit includes one common share and one transferable warrant. Each warrant permits purchase of one additional share at $0.10 per share and expires on September 4, 2027. All other private placement terms remain unchanged.
Genix Pharmaceuticals (TSXV: GENX) has completed a non-brokered private placement, raising $100,000 through the issuance of 2,000,000 units at $0.10 per unit. Each unit comprises one common share and one transferable warrant, with warrants exercisable at $0.10 per share until September 04, 2027.
The placement was entirely subscribed by company insiders - the President and CEO. The proceeds will be used for general working capital and potential new product funding. All securities issued are subject to a four-month hold period, and the offering completion remains subject to TSX Venture Exchange approval.
FAQ
What is the current stock price of Genix Pharmaceut (GENPF)?
What is the market cap of Genix Pharmaceut (GENPF)?
